Bristol-Myers Squibb Aktie
WKN: 850501 / ISIN: US1101221083
30.09.2014 23:14:12
|
Bristol-Myers To Transfer $1.4 Bln In U.S. Pension Obligations To Prudential
(RTTNews) - Biopharmaceutical company Bristol-Myers Squibb Co (BMY) said Tuesday it will settle $1.4 billion in pension obligations through the purchase of a group annuity contract from Prudential Insurance Co of America (PRU) for about 8,000 U.S. retirees and their beneficiaries who started receiving their monthly retirement benefit payments on or before June 1, 2014.
Bristol-Myers Squibb said its U.S. Retirement Plan ("the Plan") is in a strong financial position, and the obligations associated with this transaction will require no additional cash contributions by the company.
There will be no change to the monthly retirement benefit payments currently received by retirees and their beneficiaries. All other plan participants will stay in the company's Plan, which is well-funded.
Bristol-Myers said the transaction reduces risk in the Plan and better manages the ongoing variations in cost associated with its maintenance while entrusting current retirees and their beneficiaries' pensions to a financial institution with expertise in the long-term management of retirement benefits.
The company said it is committed to the long-term financial health of the Plan and has taken steps to protect all participants of the Plan.
The transfer to Prudential is expected to occur in December 2014 and is subject to satisfaction of closing conditions. Upon completion of the transfer, Prudential will assume full financial responsibility for making the annuity payments provided under the group annuity contract.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Bristol-Myers Squibb Co.mehr Nachrichten
24.04.25 |
EVOTEC-Aktie gewinnt: EVOTEC erhält Erfolgszahlungen von Bristol Myers Squibb (finanzen.at) | |
24.04.25 |
Ausblick: Bristol-Myers Squibb präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) | |
22.04.25 |
S&P 500-Titel Bristol-Myers Squibb-Aktie: So viel hätten Anleger mit einem Investment in Bristol-Myers Squibb von vor 5 Jahren verloren (finanzen.at) | |
15.04.25 |
S&P 500-Papier Bristol-Myers Squibb-Aktie: So viel Verlust hätte ein Investment in Bristol-Myers Squibb von vor 3 Jahren bedeutet (finanzen.at) | |
09.04.25 |
Zuversicht in New York: So performt der S&P 500 am Nachmittag (finanzen.at) | |
09.04.25 |
Börse New York: So steht der S&P 500 aktuell (finanzen.at) | |
09.04.25 |
Freundlicher Handel in New York: S&P 500 beginnt Sitzung im Plus (finanzen.at) | |
09.04.25 |
Erste Schätzungen: Bristol-Myers Squibb veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) |
Analysen zu Bristol-Myers Squibb Co.mehr Analysen
Aktien in diesem Artikel
Bristol-Myers Squibb Co. | 41,93 | -1,78% |
|